Exicure (XCUR) Current Deferred Revenue (2016 - 2022)
Exicure (XCUR) reported Current Deferred Revenue of $21.8 million for Q3 2022, down 29.63% on a YoY basis from $30.9 million in Q3 2021, and up 47.57% quarter-over-quarter from $14.8 million in Q2 2022.
Exicure (XCUR) Current Deferred Revenue (2016 - 2022) Analysis & Trends
Exicure has reported Current Deferred Revenue for 6 years, with the latest figure at $21.8 million in Q3 2022.
- For the quarter ending Q3 2022, Current Deferred Revenue fell 29.63% year-over-year to $21.8 million; the trailing twelve-month figure through Sep 2022 stood at $21.8 million (down 29.63% YoY), and the FY2021 full-year result was $17.3 million, changed N/A from the prior year.
- Current Deferred Revenue for Q3 2022 stood at $21.8 million, up from $14.8 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $30.9 million in Q3 2021, with the low at $14000.0 in Q3 2019.
- Historically, Current Deferred Revenue has averaged $12.5 million across 4 years, with a median of $10.9 million in 2020.
- Annual changes were most pronounced in 2020 — Current Deferred Revenue soared 60464.29% — and 2021, when it slumped 53.25%.
- Exicure's Current Deferred Revenue stood at $14000.0 in 2019, then soared by 60464.29% to $8.5 million in 2020, then jumped by 104.23% to $17.3 million in 2021, then rose by 25.74% to $21.8 million in 2022.
- The last three Current Deferred Revenue figures came in at $21.8 million (Q3 2022), $14.8 million (Q2 2022), and $26.3 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 21.77 Mn |
| Jun 30, 2022 | 14.76 Mn |
| Mar 31, 2022 | 26.26 Mn |
| Dec 31, 2021 | 17.32 Mn |
| Sep 30, 2021 | 30.94 Mn |
| Jun 30, 2021 | 7.27 Mn |
| Mar 31, 2021 | 7.35 Mn |
| Sep 30, 2020 | 8.48 Mn |
| Jun 30, 2020 | 10.88 Mn |
| Mar 31, 2020 | 15.71 Mn |
| Sep 30, 2019 | 14,000.00 |
| Jun 30, 2019 | 541,000.00 |
| Mar 31, 2019 | 975,000.00 |
| Dec 31, 2017 | 1.03 Mn |
| Dec 31, 2016 | 9.31 Mn |